Cargando…
The linkage between Churg-Strauss syndrome and leukotriene receptor antagonists: fact or fiction?
Epidemiologic evidence has shown that the worldwide prevalence of asthma is increasing. The leukotriene receptor antagonists (LTRAs) represent a new class of therapy for asthma. They have been developed in the last decade and play a pivotal steroid-sparing role in treating the inflammatory component...
Autores principales: | McDanel, Deanna L, Muller, Barbara A |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2005
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1661620/ https://www.ncbi.nlm.nih.gov/pubmed/18360552 |
Ejemplares similares
-
Churg-Strauss syndrome associated with leukotriene receptor antagonists.
por: McAuley, D. F., et al.
Publicado: (2001) -
Is Leukotriene Receptor Antagonist the Direct Cause of Churg-Strauss Syndrome in Asthmatic Patients?
por: Paul, Salomi, et al.
Publicado: (2022) -
CHURG–STRAUSS SYNDROME
por: Ghosh, Subhasish, et al.
Publicado: (2011) -
An Abdominal Presentation of Churg-Strauss Syndrome
por: Rees, J. R. E., et al.
Publicado: (2010) -
Churg-Strauss syndrome and hemorrhagic vasculitis
por: Marques, Rui Moreira, et al.
Publicado: (2011)